Biomerica (BMRA) Operating Income Growth (1y) (2011 - 2026)
Biomerica (BMRA) Operating Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn | 74.18% |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | -7.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7.27% |
| Nov 30, 2025 | -38.27% |
| Aug 31, 2025 | 18.27% |
| May 31, 2025 | -2.36% |
| Feb 28, 2025 | 39.50% |
| Nov 30, 2024 | 38.25% |
| Aug 31, 2024 | -11.04% |
| May 31, 2024 | 16.78% |
| Feb 29, 2024 | -21.14% |
| Nov 30, 2023 | 3.48% |
| Aug 31, 2023 | 40.48% |
| May 31, 2023 | -4.53% |
| Feb 28, 2023 | -1,435.83% |
| Nov 30, 2022 | -47.46% |
| Aug 31, 2022 | -34.38% |
| May 31, 2022 | -1.98% |
| Feb 28, 2022 | 95.04% |
| Nov 30, 2021 | 34.04% |
| Aug 31, 2021 | 18.90% |
| May 31, 2021 | -108.52% |